1. Total pathological complete response was not significantly different between trastuzumab and HD201. 2. HD201 has a comparable safety profile ...
Anti-tumor necrosis factor (TNF) therapies are commonly used in the treatment of patients with moderate to severe Crohn’s disease. However, ...
1. The biosimilar to infliximab, CT-P13 was shown in this study to have equivalent efficacy to the anti tumor-necrosis factor ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
